ActiMorph™ allows API (and excipients) to be granulated and dried within a single processor, with a residence time of less than a minute, producing API granules that have very high drug content (>97% by weight), flow extremely well (thus enabling accurate gravimetric feeding), do not stick or agglomerate, and have excellent compressibility.

This creates API materials with desirable properties for many Direct Compression applications, both low and high dose, both continuous and batch manufacturing